There is no decrease in efficacy but no significant benefit of enteric-coated aspirin over uncoated aspirin in patients with cardiovascular disease, post hoc results of the ADAPTABLE trial suggest.
Medscape Medical News
No Benefit of Enteric-Coated Aspirin vs Uncoated in CVD
